Recent Headlines
Within Biotechnology
Bioo Scientific Will Participate in the 2011 AOAC International Annual Meeting
Bioo Scientific announced that it will feature its industry-leading food safety testing kits at the 125th AOAC Annual Meeting in New Orleans being held September 18th – 21st. AOAC is an independent, third party organization, which brings credibility to analytical methods used for regulation... - September 17, 2011 - Bioo Scientific
atech system solutions Develops New Bioreactor Platform for Cell Culture-Based Manufacturing
The atech system solutions Ltd. presents a new generation of bioreactor systems for cell culture-based manufacturing of biopharmaceutical compounds. The new development comprises a platform technology with high performance, safety as well as environmental compatibility and simplification of cell culture-based manufacturing methods. The system platform will be marketed under the brand name “cellexis one.” - September 17, 2011 - atech system solutions Ltd.
Swarm Intelligence Enables Better Nerve Grafts
NIH funded collaborative research adds computational models of swarm intelligence based neural networks to tissue engineering. - September 17, 2011 - Stevens Institute of Technology
SalesForce4Hire Executive to Host AdvaMed 2011 Entrepreneur Bootcamp
Kevin Schimelfenig to Lead Panel Information on Capital Efficient Strategies for the Buyer, Seller and Investor - September 16, 2011 - SalesForce4Hire
Stevens and LeHigh Developing Nanotechnology for Better Natural Gas Utilization
Advances in understanding molybdenum nanostructures and molecular mechanisms of catalytic reactions to provide improved natural gas processing technologies. - September 15, 2011 - Stevens Institute of Technology
Applying New Mathematics for Robust Cryptography and a Safer Internet
Computer security experts are piggy-backing on recent developments in mathematics to pioneer new cryptography methods that will keep data safe even in the age of superfast quantum computing. - September 14, 2011 - Stevens Institute of Technology
Novus Biologicals Announces New NODAL Antibody Made Using SDIX Genomic Antibodiy Technology™
Novus Biologicals announced today a new NODAL antibody (catalog number NBP1-71686) for the study of cancer, angiogenesis and stem cells. This NODAL antibody was made using SDIX Genomic AntibodiesTM (GATTM). This NODAL Antibody (NBP1-71686) serves as an excellent tool for studying stem cell... - September 11, 2011 - Novus Biologicals
AnaSpec Introduces Industry’s First Anti-MOG ELISA Assay Kits
AnaSpec is pleased to be the first in the industry to provide Anti-MOG (Myelin Oligodendrocyte Glycoprotein) ELISA assay kits. The SensoLyte® Anti-Human MOG (1-125) IgG Quantitation ELISA Kit, SensoLyte® Anti-Mouse MOG (1-125) and SensoLyte® Anti-Rat MOG (1-125) IgG ELISA assay kits are... - September 10, 2011 - AnaSpec, EGT Group
AnaSpec Provides Industry’s Largest Collection of Anti-Tau Antibodies
In Alzheimer’s disease (AD), the major pathological hallmarks are β-sheet aggregates of β-amyloid peptides in senile plaques and hyperphosphorylated tau protein in neurofibrillary tangles (NFT).1-2 AnaSpec, a provider of one of the world’s largest collections of β-amyloid... - September 10, 2011 - AnaSpec, EGT Group
Stevens Convocation 2011 Celebrates Students and Faculty
Faculty and students award citations from Stevens Convocation, September 7, 2011. - September 10, 2011 - Stevens Institute of Technology
Stevens Researchers Pioneer Novel Technique to Make Plasmonic Nanogap Arrays
Dr. Stefan Strauf, et al. published a paper on leveraging holographic lithography for fabricating nanogap arrays with features 70 times smaller than the wavelengths of the blue laser light used to create the nanostructures. - September 08, 2011 - Stevens Institute of Technology
2011 Rocky Mountain Life Science Investor and Partnering Conference Attracts More Than 30 International Investors to Denver September 21-22
More than 30 leading biotech, device, diagnostic and pharma investors from across the country and world will be coming to Denver to create the newest deals and shape the future landscape of the life science industry. The Rocky Mountain Life Science Investor & Partnering Conference (RMLIPC) is September 21-22 at the Brown Palace Hotel. - September 07, 2011 - Colorado BioScience Association
Sweden Based Prostalund to Increase Investments in the US BPH Market
To further enhance its position in the US market, the company has decided to establish a 100% owned US subsidiary under the name CoreTherm Medical, Inc. effective from September 1st 2011. The company is located in Oldsmar, Florida. - September 06, 2011 - CoreTherm Medical Inc.
Dr. Kishore Pochiraju of Stevens Co-Authors Book on Polymeric Matrix Composites
To help engineers design longer-lasting high-performance plastics, the forthcoming book, Long-Term Durability of Polymeric Matrix Composites, presents a holistic guide to environmental degradation, damage evolution, design, and application specific issues of long term structural durability. - September 03, 2011 - Stevens Institute of Technology
ONR Funds Dr. Chang-Hwan Choi to Study Nanoscale Wetting Dynamics of Superhydrophobic Surfaces at Stevens
Dr. Choi's DURIP grant supports development of innovative anti-corrosion materials. - September 01, 2011 - Stevens Institute of Technology
BioPharm Systems Achieves Oracle PartnerNetwork Specialization for Oracle Accelerate for Midsize Companies
Oracle Recognizes BioPharm Systems for Expertise in Delivering Innovative Solutions to Midsize Companies - August 31, 2011 - BioPharm Systems
Synpromics Teams with Scottish Enterprise to Accelerate Growth
Synpromics Ltd announces the formal support of Scottish Enterprise’s High Growth Start-Up Unit (HGSU). Synpromics intends to leverage this valuable affiliation to help drive growth as the company transitions from a start-up business to an established globally-focused corporation in the future. - August 31, 2011 - Synpromics Ltd
Introducing an Optimized Process Management Concept from Drug Development to Drug Manufacturability: Advaceutics®
Reducing risk, defining time lines and increasing cost efficiency on a new drug’s way to commercial scale manufacturing. - August 26, 2011 - ProJect Pharmaceutics GmbH
NovaTeinBio Introduces New CD Antigens to Company Catalogue
Cambridge, MA-based biomedical innovator and assay development specialist NovaTeinBio has recently announced that they have introduced a new array of products to their existing catalogue of CD antigens. These new products are designed to help medical researchers to increase their understanding of... - August 25, 2011 - Novatein Biosciences
AnaSpec Offers ClearPoint™ β-Amyloid Custom Peptide Synthesis Service
AnaSpec, the world’s largest provider of β-amyloid peptide and Alzheimer’s research reagents, also provides ClearPoint™ β-Amyloid custom peptide synthesis service. ClearPoint™ peptides are AnaSpec’s trademark collection of heavy or stable isotope labeled... - August 24, 2011 - AnaSpec, EGT Group
AnaSpec Offers SensoLyte® 520 TACE Assay Kit
While fluorimetric assay kits for the detection and inhibitor screening of Tumor Necrosis Factor alpha (TNF-α) Converting Enzyme (TACE) currently exist, none of these have been able to take full advantage of the performance provided by long wavelength FRET technologies. AnaSpec’s... - August 24, 2011 - AnaSpec, EGT Group
Bioo Scientific Launches Benzo[a]pyrene ELISA to Rapidly Screen Food for Oil Spill Contaminants
The recently released MaxSignal® Benzo[a]pyrene ELISA Kit offers rapid screening of benzo[a]pyrene, a carcinogenic component of petroleum, in fish, shrimp, meat and water samples. - August 23, 2011 - Bioo Scientific
Colorado BioScience Association Serves as Catalyst in Assembling CEO Rountable Discussion for Senator Michael Bennet and FDA Commissioner Margaret Hamburg
The Colorado BioScience Association (CBSA) brought more than 35 industry CEOs together today to dialogue with Senator Michael Bennet and U.S. FDA Commissioner Margaret Hamburg at the Anschutz Medical Campus in Aurora. At Senator Bennet's request, CBSA designed today's session to share the bioscience industry's specific and unique needs in bringing innovative drugs and devices to market under current, often constraining, market conditions. - August 22, 2011 - Colorado BioScience Association
Dr. Michael Bruno of Stevens Edits Maritime Security Journal Lauded by DHS
The US Department of Homeland Security praised the May/June 2011 issue of the Marine Technology Society Journal as guest edited by Dr. Bruno from Stevens Institute of Technology. - August 20, 2011 - Stevens Institute of Technology
Solar Photovoltaic Installation Workshop at Stevens on August 25
Stevens Institute of Technology is offering a PV installation workshop on August 25 at the build site for the Empowerhouse Solar Decathlon Competition entry. - August 20, 2011 - Stevens Institute of Technology
Novus Releases New Mix-and-Match Pathway Assay Kits
Novus’ new Mix-and-Match Pathway Assay Kits allow for the simultaneous detection of activation states of multiple kinases in a signal pathway on a single multiwell platform. Their kits are designed to be much easier and faster than traditional Western blots (2.5 hour protocol), demonstrate a... - August 18, 2011 - Novus Biologicals
MoBiTec GmbH, Germany, is Offering Nuclear Receptor Fusion Proteins That Are of Importance to the Pharmaceutical Industry for FRET Interaction Studies
MoBiTec GmbH, Germany, supplier of research tools, introduces a collection of Nuclear Receptor-Ligand Binding Domain fusion proteins, carrying a GST tag, capable to bind a Europium-anti-GST antibody. With this the influence of fluorophore-labeled peptides on the ligand binding characteristics can be studied. E.g. the addition of a particular peptide might prevent the receptor from binding a ligand, thereby eliminating a response of a cell to a given stimulus. - August 17, 2011 - MoBiTec GmbH
Mouse Monoclonal DUX4 Antibody Announced by Novus Biologicals
DUX4 is a transcriptional activator of PITX1, whose expression is epigenetically suppressed in differentiated tissues. DUX4 defects are suspected to cause facioscapulohumeral dystrophy (FSHD), a degenerative skeletal muscle disease and one of the most common muscular dystrophies. In FSHD... - August 17, 2011 - Novus Biologicals
AnaSpec Offers Monoclonal Antibody, Anti-5-Methylcytidine
AnaSpec, EGT Group is pleased to offer Eurogentec’s popular monoclonal antibody, anti-5-methylcytidine (Clone 33D3) for use in epigenetics research. Purified from ascites, this IgG1 / λ isotype antibody is supplied as a 1 mg/ml solution (in PBS) and is available in three sizes (0.1 mg,... - August 14, 2011 - AnaSpec, EGT Group
AnaSpec Highlights Calcein AM with High Purity Grades
AnaSpec is pleased to provide Calcein AM at two purity grades, >90% or >95%, as determined by HPLC. AnaSpec also offers the SensoLyte® Calcein Cell Viability Assay Kit - a rapid and sensitive assay to detect viable cells. This kit provides ample reagents (dye and assay buffer) for 1000... - August 14, 2011 - AnaSpec, EGT Group
Professor Attygalle of Stevens Lectures at a Max Planck Institute on Mass Spectrometry
Mass spectrometry expert Dr. Athula Attygalle from Stevens Institute of Technology lectured at a Max Planck Institute in Jena, Germany, earlier this summer. - August 11, 2011 - Stevens Institute of Technology
Thirty Regional Companies Selected to Present at the 2011 Rocky Mountain Life Science Investor Conference in Denver
The 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will bring 30 of the region’s most innovative private and public life science companies together to present to a targeted audience of biotech, device, diagnostic and pharma investors and strategic partners. The conference is being held September 21-22 at The Brown Palace Hotel, Denver, CO. - August 10, 2011 - Colorado BioScience Association
FDA Supplier Management Conference Chaired by Cerulean's John Avellanet
Cerulean's John Avellanet will chair a three-day conference of FDA officials and industry veterans discussing key regulatory requirements and industry best practices for managing suppliers and conducting supplier qualification. - August 05, 2011 - Cerulean Associates LLC
SalesForce4Hire® Releases White Paper on a "Shared Risk – Shared Reward" Sales Model
Leading Custom Sales Solutions Company Addresses Advantages of a Strategic Sales Partner Over Traditional Outsourced Sales Organizations - August 05, 2011 - SalesForce4Hire
Mitegen Announces Distribution of AP Innovation's Quick Puck Loader
Innovative Tool increases speed and reduces errors during puck loading - August 03, 2011 - MiTeGen, LLC
Colorado Institute for Drug, Device and Diagnostic Development Awards Funding to Flashback Technologies
The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has selected Longmont, CO-based Flashback Technologies, Inc. to receive funding and management assistance. - August 03, 2011 - Colorado Institute for Drug, Device and Diagnostic Development
Mouse Monoclonal ABCG8 Antibody Announced by Novus Biologicals
Novus Biologicals announced today a new mouse monoclonal ABCG8 antibody. ABCG8 is an ATP binding cassette family member which acts to exclude non-cholesterol sterol entry to the intestine, to promote excretion of cholesterol and sterols into bile, and to facilitate transport of sterols back into... - August 03, 2011 - Novus Biologicals
BioPharm Systems to Present at the 16th Annual Oracle Health Sciences User Group Meeting
Leading IT consulting company focused on the implementation and hosting of clinical trial software will speak at Oracle's annual event. - August 03, 2011 - BioPharm Systems
AbboMax Announces the Availability of New Mouse Anti-Desmoglein 3 (Dsg3) Monoclonal Antibody
Desmogleins are calcium-binding transmembrane glycoproteins, members of the desmosomal cadherins that provide adhesive integrity to desmosomes between adjoining keratinocytes. Desmoglein 3 protein has been identified as the autoantigen of the autoimmune skin blistering disease pemphigus vulgaris and plays important roles in human squamous cell cancer. - August 03, 2011 - AbboMax, Inc.
Novus Biologicals Announces VMAT2 Antibody Made Using SDIX Genomic Antibodies™
Novus Biologicals announced today a new VMAT2 antibody (NBP1-69750) for use in neurotransmission research. This VMAT2 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). VMAT2 is a multipass membrane protein responsible for vesicular transport of neurotransmitters by pumping... - August 01, 2011 - Novus Biologicals
New Products Now Available Via the NovaTeinBio Website
Boston based biological reagents provider, NovaTeinBio Inc. has recently announced that they have added new products to their varied catalogue. The new products are an addition to the already outstanding array of solutions that the company offers to their clients across the scientific... - July 31, 2011 - Novatein Biosciences
Tracking Environmental Monitoring Trends Crucial to Regulatory Compliance, OsoBio Expert Says
A microbiology laboratory manager at OSO BioPharmaceuticals Manufacturing, LLC, has authored a chapter on environmental monitoring trends for an industry reference manual. Kim Van Antwerpen wrote a chapter for “Environmental Monitoring: A Comprehensive Handbook (vol. 5)” edited by... - July 30, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
Stevens Professor EH Yang Receives DURIP Grant to Support Nanoscale Imaging
Dr. Yang's AFOSR-sponsored DURIP grant allows him to purchase a scanning probe microscope capable of imaging in ambient conditions. - July 29, 2011 - Stevens Institute of Technology
Dr. Chandramouli of Stevens Gives Keynote on Dynamic Spectrum Access at Wireless Security Conference
Dr. R. Chandramouli of Stevens gave the Wireless Summit track keynote lecture, “Dynamic Spectrum Access Wireless Networking," at the NIKSUN World Wide Security & Mobility Conference 2011 (NIKSUN WWSMC) in Princeton, NJ, on July 27. - July 29, 2011 - Stevens Institute of Technology
Colorado Institute for Drug, Device and Diagnostic Development Sets August 5th as Submission Date for New Project Consideration
The Colorado Institute for Drug, Device and Diagnostic Development (CID4) is seeking its fifth project and a review date of Friday, August 5th has been selected as the cut-off for submitting material to CID4.com for consideration. - July 27, 2011 - Colorado Institute for Drug, Device and Diagnostic Development
Exploring Science Through Underwater Robotics
The Center for Innovation in Engineering and Science Education at Stevens is leading a National Science Foundation initiative to improve K-12 STEM skills and education through fun summer camps and educator institutes. - July 27, 2011 - Stevens Institute of Technology
Raybiotech Launches Risk-Free Trial Program for ELISA Kits
RayBiotech, Inc., has just launched a Risk-Free Trial on its ELISA kits, stipulating that if a researcher is unsatisfied with the performance of any RayBio® ELISA, EIA, or phosphorylation ELISA, they can receive a full product refund or credit. - July 22, 2011 - RayBiotech, Inc
Stevens Students Win 5th in International Autonomous Surface Vehicle Competition
The Stevens team won 5th at the International RoboBoat Competition, held June 9-12 in Virginia Beach. - July 21, 2011 - Stevens Institute of Technology
Valencia Practice Adpots New and Discreet STARR Weight-Loss Treatment
Town Center Surgery’s Dr. Monali Misra praises privacy and comfort of new procedure, no visible scars. - July 21, 2011 - TransEnterix
AnaSpec Expands SensoLyte® MMP Assay Kits Collection
Since its introduction, AnaSpec, EGT Group’s product line of SensoLyte® 520 MMP Assay Kits has become the new standard in MMP assay sensitivity. These fluorescence resonance energy transfer (FRET)-based assay kits utilizing the 5-FAM/QXL™ 520 are some of the most sensitive and... - July 17, 2011 - AnaSpec, EGT Group